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a b s t r a c t
Aim: The place of adjuvant radiotherapy in the treatment of sinonasal melanoma.
Background: Sinonasalmucosalmelanoma is a rare disease with poor prognosis and requires
a complex treatment. Elective neck dissection in patientswithN0 and adjuvant radiotherapy
has been a source of controversy. High late regional recurrence rates rise questions about
elective irradiation of the neck nodes in patients with N0 stage disease.
Methods: We present our two years’ follow up in a case of locally advanced sinonasal
melanoma and literature review of the treatment options for mucosal melanoma.
Results: In locally advanced sinonasal melanoma treated with surgical resection, postopera-
tive radiotherapy and chemotherapy we had local tumor control. Two years later, a regional
contralateral recurrence without distant metastasis occurred.Conclusions: Literature data for frequent neck lymph nodes recurrences justify elective neck
dissection. Postoperative elective neck radiotherapy for patients with locally advanced
sinonasal melanoma and clinically N0 appears to decrease the rate of late regional recur-
land
rences.
© 2010 Greater Po
1. Introduction
Malignant melanoma affecting the nasal cavity and paranasal
sinuses is a rare disease1–5 with a poor prognosis.3,12–16 Opti-
mal complex treatment and the role of adjuvant radiotherapy
for sinonasal melanoma remains an open issue.13
2. Case reportsA 65-years-old male with locally advanced paranasal malig-
nant melanoma. According to Tanaka et al. the types of
melanoma are histologically subdivided into nonpigmented
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mixed type.17,18 Immunohistochemistry – the tumor cells
strongly expressed S-100 protein and HMB-45 monoclonal
antibody microstaging as described by Prasad et al. Level III,
deep invasion into surrounding tissue.2,3,9,10
CT scan-head and neck – tumor, involving right nasal cav-
ity, right paranasal sinuses-maxillary, ethmoidal, frontal and
retrobulbar space. There is no evidence for positive cervical
lymph nodes (Fig. 1). The stage was deﬁned according to the
Union International Contre le Cancer stage I (conﬁned to thety – Varna, 100 Tsar Osvoboditel Str., Varna, Bulgaria.
primary site without positive cervical lymph nodes).9
Surgery – a mediofascial resection with positive excision
margins R2 was done. Postoperative CT scan demonstrates
residual tumor in all paranasal sinuses (Fig. 2).
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.



















mig. 1 – Preoperative CT scan – locally advanced sinonasal
elanoma.
CT scans of the brain, thorax and abdomen were nega-
ive. Bone scan showed no metastases. Postoperative external
eam radiation therapy to total dose of 70Gy was performed.
onventional radiotherapy was prescribed. CTV covered also
he right eye and retrobulbar space, due to tumor inﬁltration.
T scan (one month after radiotherapy) – tumor reduction
round 80%, tumor size – 15–20mm, localized in the right
rontal and ethmoidal sinuses (Fig. 3).
Five cycles of chemotherapy with Vinblastin – 1.2mg/m
or 1–4 days, Cisplatinum – 25–50mg/m for 1–4 days, DTIC –
00mg/m for 1 day were applied. MRI imaging after the fourth
ycle showed poor response to systemic treatment (Fig. 4).
Second surgical excision was performed. Surgical margins
ere macroscopic and microscopic clear – R0. MRI imaging six
onths after the re-surgery showed no evidence of disease –
ocal tumor control(Fig. 5).
Two years after the treatment, PET/CT was performed. The
esults revealed metastatic contralateral neck lymph nodes
25–27mm). Selective left neck dissection was done. Patho-
ogic examination showed lymphnodeswithmetastases from
alignant melanoma with pigment.
Fig. 2 – Postoperative CT scan – residual tumor.Fig. 3 – CT scan – one month after postoperative
radiotherapy – residual tumor.
3. Discussion
Our observations rise a number of questions: (1) What is the
optimal complex treatment according to local tumor control
and disease free survival? (2) What is the beneﬁt from adju-
vant radiotherapy in locally advanced sinonasal melanoma?
(3) What is the role of elective neck irradiation (in patients
with N0 disease)?
At the time of diagnosis, sinonasal melanoma is often
locally advanced5 with all paranasal sinuses affected, includ-
ing retrobulbar inﬁltration (our case). Treatment of choice
for mucosal melanoma is radical surgical excision with clear
margins.1,14–16 This is possible for early stage melanomas,
without inﬁltration in adjacent structures. The literature data
for incidence of lymph node metastases is controversial –
rare (below 6%)16 or frequent.8 Metastatic neck lymph nodes
worsen the prognosis and require neck dissection.17,18 It is
curative only for 30% of cases, because the others already have
occult distant metastases.19
Despite high rates of local and regional recurrences
in patients with N0, elective neck dissection is still
controversial.5 It seems that the dissection is beneﬁcial in
selective group of patients – with deep inﬁltration and high
risk of occult lymph node metastases.16,19 Elective neck
dissectionwill probably improve the rates of local neckmetas-
tases and disease free survival.
In our case we have a contralateral late regional recurrence
two years after treatment, without local relapse and distant
metastases. According to McMasters et al., in the neck region,
drainage patterns vary and tend to be a higher number of sen-
tinel lymph nodes.21 Lymph drainage is unpredictable and it
ismandatory to perform preoperative lymphoscintigraphy.5,22
If interval sentinel lymph nodes are negative, there is no place
for lymphadenectomy. In stage 3 disease (without palpable
neck nodes), we should suggest elective neck dissection.5
Postoperative radiotherapy in patientswith R1–R2 resection
is indicated, although melanoma has always been considered
as a radioresistant tumor.14,23–25 Irradiation ismore often used
in the sinonasal melanoma because of the difﬁculty in obtain-
ing satisfactory clear surgical margins in this region 8. We
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Fig. 4 – MRI imaging – residual tumor in the right frontal sinus and ethmoidal cells without right eye inﬁltration.
surgFig. 5 – MRI imaging – local tumor control – after
report 80% regression of the tumor after total dose of 70Gy
and after second operation we have local tumor control for
two years. Many authors published data for improved loco-
regional control after adjuvant radiotherapy, without survival
beneﬁt because of the high rate of distant metastases.8,13,26,27
Local control of three years was at 57% after surgery alone and
71% after surgery and adjuvant radiotherapy.28 Some authors
reported improvement in loco-regional control with postoper-
ative radiotherapy only for patients with early stage disease.27
Many investigators recommend postoperative radiother-
apy for patients with advanced stage melanoma with
positive surgical margins (R1–R2) and pN1 with extracapsu-
lar extension.13 Adjuvant radiotherapy resulted in a 10-year
regional control rate of 94%. The authors recommend adju-
vant irradiation for patients with extracapsular extension,
lymphnodesmeasuring 3 cm in size or larger, the involvement
of multiple lymph nodes, recurrent disease, or any patient
having undergone a selective therapeutic neck dissection.25The optimal radiotherapy schedule and the fractionation
remain uncertain. Most authors suggest high dose per frac-
tion for macroscopic disease and standard fractionation for
microscopic remnants.30 Clinical target volume in sinonasalical changes in maxillary and paranasal sinuses.
melanoma often includes many critical tissues and organs,
thus increasing the risk of late complications. High incidence
of local and regional recurrences even after neck dissection
rises questions about elective irradiation of neck lymph nodes
in patients with N0 disease.28,31 We agree with this approach
and recommend adjuvant irradiation of primary tumor and
neck lymph nodes in patients with locally advanced sinonasal
melanoma with clinically N0.23,24
4. Conclusions
• In locally advanced sinonasal melanoma we had local
tumor control after multimodality treatment (mediofas-
cial resection, postoperative radiotherapy, ﬁve cycles of
chemotherapy and re-surgery).
• Late local relapses (in our case – two years after treatment)
require careful investigation of neck lymph nodes at the
time of diagnosis.
• Literature data for frequent lymph node metastasis in
sinonasal melanoma justify elective neck dissection.
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Postoperative elective neck lymph nodes radiotherapy in
patients with locally advanced sinonasal melanoma (N0)
decreases the rate of late regional recurrences.
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